跳至主要内容
临床试验/NCT05452863
NCT05452863招募中不适用

Automatic Oxygen Supply With the O2matic Device for the Treatment of Hospitalized Heart Patients With Hypoxia

Hvidovre University Hospital2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Time in designated saturation interval

研究概览

简要总结

Automatic oxygen supply with the O2matic device has been shown to provided an enhanced oxygen treatment in patients with hypoxemia. O2matic was significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia in patients suffering from chronic obstructive pulmonary disease. This trial investigates the effect of using O2matic in hypoxic patients submitted to the Department of Cardiology.

详细描述

Oxygen supply to patients with cardiovascular disease has been subject to several investigations. Both too much and too little oxygen is supposed to be harmful. The O2matic device is a new way of supplying oxygen treatment which is significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia. The device has past favorable tests in patients suffering from chronic obstructive pulmonary disease. This study investigates the application of the O2matic device on hypoxic patients admitted to the Cardiology ward.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with heart disease and an oxygen saturation below 94% admitted to the Department of Cardiology
  • Age of 30 or more
  • Intellectual capacity to participate in the trial
  • Willing to give informed accept of participation in the trial.

排除标准

  • Unstable patients
  • Need for ventilatory support except intermittent continuous positive airway pressure
  • Fertile women (age<55 years) with a positive pregnancy test
  • Unable to participate due to language or cognitive problems

结局指标

主要结局

Time in designated saturation interval

时间窗: 24 hours of treatment

We have predefined an optimum saturation interval of 92-96% with a target of 93%

次要结局

  • Time with hypoxemia(24 hours of treatment)
  • Time with hyperoxemia(24 hours of treatment)
  • Time with severe hypoxemia(24 hours of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jens D Hove, MD,PHD

Associate Professor, MD, PhD

Hvidovre University Hospital

研究点 (2)

Loading locations...

相似试验